What is ICON?
ICON is a clinical research organization company serving enterprise, public-sector, commercial, consumer, or regulated-market customers.
- Category
- Clinical research organization
- Headquarters
- Dublin, Ireland
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: ICLR
What is ICON?
ICON is a clinical research organization company headquartered in Dublin, Ireland. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
ICON is a clinical research organization company headquartered in Dublin, Ireland. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, ICON should be mapped as a scaled public-company account rather than an early-stage company. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does ICON offer?
ICON's profile centers on Clinical trials, Development consulting, Laboratory services, Patient recruitment.
- Clinical trials· Clinical research organization
- Development consulting· Clinical research organization
- Laboratory services· Clinical research organization
- Patient recruitment· Clinical research organization
- Data analytics· Clinical research organization
- Regulatory support· Clinical research organization
How does ICON make money?
ICON makes money through commercial activity tied to clinical research organization.
ICON monetizes through the model common to clinical research organization: product sales, recurring services, subscriptions, contracts, distribution, transaction volume, underwriting, regulated utility revenue, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, uptime, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads ICON?
ICON's named executives should be verified on the official leadership or investor-relations page before outreach.
- ICON executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- ICON finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- ICON operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact ICON's leadership?
ICON should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.iconplc.comHow is ICON funded?
ICON's current status is Public company; Nasdaq: ICLR.
ICON's capital profile is best understood through its current public-company status: Public company; Nasdaq: ICLR. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capex plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did ICON get here?
ICON's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingICON is foundedThe company begins building in clinical research organization.
- Scale-upCommercial footprint expandsICON broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: ICLRPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are ICON's competitors?
ICON competes with larger incumbents and focused specialists in clinical research organization.
- Thermo Fisher ScientificLife sciences tools, diagnostics, and services incumbent.
- DanaherLife sciences and diagnostics platform company.
- MedtronicGlobal medical technology competitor.
- PfizerLarge pharmaceutical company with global commercial reach.
- IQVIAHealthcare data and clinical research platform competitor.
ICON — frequently asked questions
